CD276 and neoplasm: A significant glucose competition between tumor cells and CD8+ T cells is evident, and B7-H3 plays a pivotal role in augmenting tumor cells' capacity to compete for glucose resources, resulting in the suppression of CD8+ T cell glycolysis.